Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 98 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 7737174

    Indole inhibitors of MDM2 and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 15, 2010 · Expires Jun 10, 2030

    granted

  2. US 7737151

    Pyrazine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 15, 2010 · Expires Jun 10, 2030

    granted

  3. US 7732446

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 8, 2010 · Expires Jun 3, 2030

    granted

  4. US 7732475

    Histone deacetylase inhibitors

    Takeda San Diego, Inc. · Granted Jun 8, 2010 · Expires Jun 3, 2030

    granted

  5. US 7732445

    Myosin light chain kinase inhibitor compounds, compostions and related methods of use

    Northwestern University · Granted Jun 8, 2010 · Expires Jun 3, 2030

    granted

  6. US 7728017

    Inhibitors of c-Met and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

  7. US 7728148

    Acyclic oximyl hepatitis C protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

  8. US 7727992

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

  9. US 7723344

    Dipeptidyl peptidase inhibitors

    Takeda San Diego, Inc. · Granted May 25, 2010 · Expires May 20, 2030

    granted

  10. US 7718769

    Tri-peptide hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted May 18, 2010 · Expires May 13, 2030

    granted

  11. US 7718612

    Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted May 18, 2010 · Expires May 13, 2030

    granted

  12. US 7713973

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 11, 2010 · Expires May 6, 2030

    granted

  13. US 7709190

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted May 4, 2010 · Expires Apr 29, 2030

    granted

  14. US 7709482

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 4, 2010 · Expires Apr 29, 2030

    granted

  15. US 7705164

    Metalloprotein inhibitors

    The Regents of the University of California · Granted Apr 27, 2010 · Expires Apr 22, 2030

    granted

  16. US 7700609

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted

  17. US 7696218

    Substituted 1,3-dialkyl-2,4-dioxo-6-(arylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxamic acid inhibitors of MAPK/ERK kinase

    Takeda San Diego, Inc. · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted

  18. US 7696227

    Small-molecule inhibitors of the androgen receptor

    The Regents of the University of California · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted

  19. US 7691853

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted

  20. US 7691885

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted

  21. US 7687459

    Arylalkoxyl hepatitis C virus protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted

  22. US 7687638

    Dipeptidyl peptidase inhibitors

    Takeda San Diego, Inc. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted

  23. US 7687506

    Selective serine/threonine kinase inhibitors

    The Regents of the University of California · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted

  24. US 7687660

    Process for preparing intermediates of HMG-CoA reductase inhibitors

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.